Executive Summary: Cancer Therapeutics: The Worldwide Market , 2nd Edition

Kalorama Information Executive Summaries
February 1, 2007
8 Pages - SKU: KLE1467850
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Recurrent Head  |  read more...
USD 2,000
Conference Documentation: Cancer Vaccines
9/15/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Cancer Vaccines SMi present the 3rd Annual Cancer Vaccines Conference taking place in Central London on Monday 15th and Tuesday 16th September 2014. This year's event will focus on  |  read more...
USD 788.78
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide
9/9/2014 | published by: Renub Research
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was  |  read more...
USD 1,490
Uterine Cancer - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
Uterine Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Uterine Cancer - Pipeline Review, H2 2014’, provides an overview of the Uterine Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Uterine  |  read more...
USD 2,000
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) – Global Forecast to 2023
9/10/2014 | published by: MarketsandMarkets
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) – Global Forecast to 2023 Need for early  |  read more...
USD 4,650
Global Non-small Cell Lung Cancer Market : 2014-2018
9/10/2014 | published by: TechNavio - Infiniti Research Ltd.
Global Non-small Cell Lung Cancer Market 2014-2018 About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of  |  read more...
USD 2,500
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting
9/15/2014 | published by: GBI Research
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting Summary GBI Research, the leading business intelligence provider, has released its latest research, ‘Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to  |  read more...
USD 4,995
Metastatic Ovarian Cancer - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Metastatic Ovarian Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Anaplastic Thyroid Cancer - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Anaplastic Thyroid Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Anaplastic Thyroid Cancer - Pipeline Review, H2 2014’, provides an overview of the Anaplastic Thyroid Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
8/14/2014 | published by: FirstWord
Introduction As the oncology drug market continues to face significant road bumps in terms of development costs and pricing requirements, the role of Medical Affairs teams working with oncologists becomes ever more critical. Fine tuning their performance  |  read more...
USD 3,900
 

SELECT A LICENSE

    Online Download  USD 500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!